These studies showed that treatment with AD was mediated by up-regulation of TERT via the stimulation of the intracellular estrogen receptor and, as a consequence, enhancement of the enzymatic activity of telomerase [18,21]. The gene discussed is TERT; the disease is Alzheimer disease.